Oleptro. Oleptro drug in the treatment of major depressive disorder has been recently approved by US FDA
Feb.09, 2010
US Food and Drug Administration (FDA) approved medication Oleptro (trazadone hydrochloride) in the form of extended release tablets for use once daily in the treatment of depressive disorders in adults. Oleptro was launched by the pharmaceutical company Labopharm.
Oletpro is approved to treat major depressive disorder (MDD).
